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Background: The randomized ECOST study confirmed the safety and effectiveness of long-term remote monitoring (RM) of implantable 
cardioverter defibrillators (ICD). We compared the overall costs of RM with those of ambulatory follow-up (AFU) on the long term.
methods: ECOST randomly assigned 433 ICD recipients to RM versus AFU. Patients assigned to RM were seen once a year unless the system 
reported an ICD dysfunction or a clinical event mandating an ambulatory visit. Patients assigned to AFU were seen in the ambulatory department 
every 6 months. This analysis included 310 patients. Instead of using the expected costs based on a theorical act schedule, we calculated and 
compared the long-term individual costs associated with each follow-up strategy, using the actual billing documents issued by the French national 
health insurance system, including 1) costs of non-hospital care (all cardiovascular procedures, all ICD-related or unrelated ambulatory visits and 
ICD associated transportation costs) and 2) costs of hospitalizations for management of cardiovascular disorders.
results: The characteristics of the study groups were similar. Over a follow-up of 27 months, the mean costs (± standard deviation) of non-hospital 
care were €568 ± 349 per patient-year in the RM, versus €712 ± 414 per patient-year in the AFU group, a €144 per patient-year (20%) cost saving 
(p<0.001). The mean costs of hospitalizations per patient-year for management of cardiovascular disorders in the RM (€2,829 ± 6,382) versus the 
AFU (€3,549 ± 9,714) group were similar.
conclusions: In this initial randomized comparison, which did not include the costs of the RM system and of ICD, the costs of non-hospital, long-
term RM of ICD were significantly lower than the costs of AFU.
